A majority of the published cancer prognostic studies dichotomise CRP at 10 mg l–1 (Mahmoud and Rivera, 2002; Maltoni et al, 2005; McMillan, 2008), and the Glasgow Prognostic Score uses the same cut-off (Forrest et al, 2003). This evidence concerns the gene CRP and cancer.